[1] EGGER G,LIANG G,APARICIO A,et al.Epigenetics in human diseaseand prospects for epigenetic therapy[J].Nature,2004,429 (6990):457.
[2] LV LV,ZHOU J,LIN C,et al.DNA methylation is involved in the aberrant expression of miR-133b in colorectalcancer cells[J].Oncol Lett,2015,10(2):907.
[3] MOHAJERI G,MOHAJERI MR,AFSHR-MOGHADDAM N,et al.The significance of clinicopathological aspects of tumor for the detection of liver micrometastasis in patients with colorectal cancer [J].J Res Med Sci,2014,19(5):410.
[4] BILIR C,ENGIN H,TEMI YB.Effect of gender on coagulation functions:a study in metastatic colorectal cancer patients treated with bevacizumab,irinotecan,5-Fluorouracil,and leucovorin[J].Adv Hematol,2014,13(5):473.
[5] OHTSUKA M,LING H,DOKI Y,et al.MicroRNA Processing and Human Cancer[J].J Clin Med,2015,4(8):1651.
[6] KEDMI M,SAS-CHEN A,YARDEN Y.MicroRNAs and growth factors:an alliance propelling tumor progression[J].J Clin Med,2015,4(8):1578.
[7] MANSOORI B,MOHAMMADI A,SHIRJANG S,et al.Micro-RNAs:the new potential biomarkers in cancer diagnosis,prognosis andcancer therapy[J].Cell Mol Biol(Noisy-le-grand),2015,61(5):1.
[8] GARG M.Emerging role of microRNAs in cancer stem cells:implications in cancertherapy[J].World J Stem Cells,2015,7(8):1078.
[9] TUTAR L,TUTAR E,ZGUR A,et al.Therapeutic targeting of microRNAs in cancer:future perspectives[J].Drug Dev Res,2015,76(7):382.
[10] THOMAS J,OHTSUKA M,PICHLER M,et al.MicroRNAs:clinical relevance in colorectal cancer[J].Int J Mol Sci,2015,16(12):28063.
[11] FONKEN LK,GAUDET AD,GAIER KR,et al.MicroRNA-155 deletion reduces anxiety- and depressive-like behaviors in mice[J].Psychoneuroendocrinology,2015,63:362.
[12] LIU J,SHI K,CHEN M,et al.Elevated miR-155 expression induces immunosuppression via CD39+ regulatory T-cells in sepsis patient[J].Int J Infect Dis,2015,40:135.
[13] PATHAK S,GRILLO AR,SCARPA M,et al.MiR-155 modulates the inflammatory phenotype of intestinal myofibroblasts by targeting SOCS1 in ulcerative colitis[J].Exp Mol Med,2015,47(5):e164.
[14] ZHUANG Z,QIN X,HU H,et al.Down-regulation of microRNA-155 attenuates retinal neovascularization via the PI3K/Akt pathway[J].Mol Vis,2014,21:1173.
[15] RANGANATH P.MicroRNA-155 and its role in malignant hematopoiesis[J].Biomark Insights,2015,10:95.
[16] HUSKOVA H,KORECKA K,KARBAN J,et al.Oncogenic microRNA-155 and its target PU.1:an integrative gene expression study in six of the most prevalent lymphomas[J].Int J Hematol,2015,102(4):441.
[17] YU DD,LV MM,CHEN WX,et al.Role of miR-155 in drug resistance of breast cancer[J].Tumour Biol,2015,36(3):1395.
[18] HAN S,YANG S,CAI Z,et al.Anti-Warburg effect of rosmarinic acid via miR-155 in gastric cancer cells[J].Drug Des Devel Ther,2015,9:2695.
[19] ARTS N,CANE S,HENNEQUART M,et al.microRNA-155,induced by interleukin-1,represses the expression of microphthalmia- associated transcription factor (MITF-M) in melanoma cells[J].PLoS One,2015,10(4):e0122517.
[20] PANG W,SU J,WANG Y,et al.Pancreatic cancer-secreted miR-155 implicates in the conversion from normal fibroblasts to cancer-associated fibroblasts[J].Cancer Sci,2015,106(10):1362.
[21] LIU F,KONG X,LV L,et al.TGF-β1 acts through miR-155 to down-regulate TP53INP1 in promoting epithelial-mesenchymal transition and cancer stem cell phenotypes[J].Cancer Lett,2015,359(2):288.
[22] LIU M,ZHOU K,HUANG Y,et al.The candidate oncogene (MCRS1) promotes the growth of human lung cancer cells via the miR-155-Rb1 pathway[J].J Exp Clin Cancer Res,2015,34:121.
[23] HUANG J,JIAO J,XU W,et al.miR-155 is upregulated in patients with active tuberculosis and inhibits apoptosis of monocytes by targeting FOXO3[J].Mol Med Rep,2015,12(5):7102.
[24] THOMSEN KG,TERP MG,LUND RR,et al.miR-155,identified as anti-metastatic by global miRNA profiling of a metastasis model,inhibits cancer cell extravasation and colonization in vivo and causes significant signaling alterations[J].Oncotarget,2015,6(30):29224.